The 290.1% one‑year return, beating the S&P’s 266.4% by over 20 points, underscores UCTT’s ability to generate outsized gains in a high‑growth niche, making it a compelling candidate for momentum‑focused investors.
The stock’s extraordinary returns are heavily tied to cyclical infrastructure spending; a 10% slowdown in global water‑treatment capital expenditures could shave roughly 5–7 percentage points off its long‑term CAGR, introducing material downside risk if policy or funding environments shift.
While institutional ownership is ultra‑high, the concentration creates a crowding risk; a coordinated shift in sentiment among these investors could trigger rapid outflows, potentially magnifying price declines beyond the historical -29.7% drawdown if a sector slowdown occurs.
The negative three‑year CAGR of -4.7% is a red flag for investors because it signals that revenue contraction is not transitory; without a clear turnaround catalyst, earnings momentum will likely remain weak.
The net margin of -8.8% translates to an $185 M loss on a $2.1 B revenue base; if the company cannot improve its gross margin or contain SG&A, each 1% drop in revenue would increase losses by roughly $21 M, intensifying solvency risk.
The 6.5‑percentage‑point swing in operating margin (-2.3% to -8.8%) is the dominant factor eroding ROE, signaling that cost structure pressures are overwhelming any gains from higher asset turnover.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | -25.5 | -8.8 | 1.19 | 2.43 | 3.1 | 3.1 | -10.5 |
| 2024 | 2.7 | 1.1 | 1.09 | 2.20 | 5.8 | 5.8 | 1.2 |
| 2023 | -3.7 | -1.8 | 0.93 | 2.23 | 2.3 | 2.3 | -1.7 |
| 2022 | 4.6 | 1.7 | 1.21 | 2.21 | 7.9 | 7.7 | 2.1 |
| 2021 | 14.1 | 5.7 | 1.04 | 2.39 | 12.3 | 11.9 | 5.9 |
| 2020 | 14.6 | 5.5 | 1.27 | 2.07 | 13.9 | 13.5 | 7.0 |
| 2019 | -2.2 | -0.9 | 1.05 | 2.33 | 3.8 | 3.7 | -0.9 |
| 2018 | 8.4 | 3.3 | 1.14 | 2.21 | 7.5 | 7.4 | 3.8 |
| 2017 | 25.0 | 8.1 | 1.66 | 1.86 | 25.6 | 25.1 | 13.4 |
| 2016 | 4.7 | 1.8 | 1.48 | 1.76 | 8.1 | 8.0 | 2.6 |
| 2015 | -5.3 | -2.3 | 1.40 | 1.67 | 2.2 | 2.2 | -3.2 |
The 78‑day CCC represents a $12 million cash drag (assuming average daily sales of $150k), which could exacerbate funding pressures if the loss margin persists, raising the risk of liquidity shortfalls.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 307 | 82 | 37 | 86 | 41 | 78 |
| 2024 | 334 | 80 | 42 | 85 | 45 | 77 |
| 2023 | 393 | 94 | 38 | 101 | 48 | 84 |
| 2022 | 301 | 85 | 39 | 58 | 48 | 75 |
| 2021 | 352 | 83 | 43 | 57 | 73 | 54 |
| 2020 | 288 | 59 | 38 | 51 | 40 | 57 |
| 2019 | 349 | 72 | 39 | 62 | 56 | 55 |
| 2018 | 320 | 74 | 36 | 48 | 39 | 70 |
| 2017 | 220 | 112 | 36 | 13 | 84 | 64 |
| 2016 | 247 | 80 | 48 | 12 | 55 | 73 |
| 2015 | 262 | 67 | 46 | 13 | 36 | 76 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1729M | $945M | $711M | $810M | $498M | $312M | $960M | $301M |
| 2024 | $1920M | $984M | $874M | $660M | $346M | $314M | $970M | $336M |
| 2023 | $1868M | $970M | $839M | $640M | $333M | $307M | $893M | $310M |
| 2022 | $1961M | $1024M | $888M | $611M | $252M | $359M | $1099M | $389M |
| 2021 | $2025M | $1133M | $849M | $635M | $169M | $466M | $1137M | $469M |
| 2020 | $1103M | $551M | $533M | $312M | $111M | $200M | $545M | $201M |
| 2019 | $1019M | $567M | $437M | $334M | $172M | $162M | $467M | $211M |
| 2018 | $962M | $510M | $436M | $341M | $197M | $144M | $459M | $142M |
| 2017 | $558M | $258M | $300M | $52M | $-16M | $68M | $402M | $202M |
| 2016 | $381M | $165M | $216M | $68M | $15M | $52M | $237M | $101M |
| 2015 | $336M | $135M | $201M | $76M | $25M | $50M | $190M | $65M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $65M | $-47M | $-21M | $-50M | $15M | $-3M | |
| 2024 | $65M | $-64M | $10M | $-64M | $2M | $-0M | |
| 2023 | $136M | $-120M | $-70M | $-76M | $60M | $-29M | $-0M |
| 2022 | $47M | $-96M | $-56M | $-100M | $-53M | $-12M | $-0M |
| 2021 | $212M | $-405M | $461M | $-59M | $152M | ||
| 2020 | $97M | $-30M | $-31M | $-36M | $61M | ||
| 2019 | $121M | $-49M | $-53M | $-26M | $95M | $-1M | |
| 2018 | $45M | $-349M | $380M | $-29M | $16M | ||
| 2017 | $49M | $-16M | $-17M | $-16M | $33M | ||
| 2016 | $18M | $-7M | $-8M | $-7M | $10M | ||
| 2015 | $1M | $-55M | $25M | $-10M | $-9M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net